Trials / Completed
CompletedNCT02395744
The COPPER-B Trial
The Occlusion Perfusion Catheter for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Below the Knee
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Horizons International Peripheral Group · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the COPPER - B study is to assess the feasibility, safety, and initial efficacy of paclitaxel administration using the OPC for the prevention of restenosis in infrapopliteal de novo and restenotic lesions and occlusions using a novel catheter, the OPC.
Conditions
- Cardiovascular Diseases
- Peripheral Vascular Disease
- Arterial Occlusive Diseases
- Peripheral Arterial Disease
- Critical Limb Ischemia
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Paclitaxel administration using the OPC |
Timeline
- Start date
- 2015-03-11
- Primary completion
- 2016-08-15
- Completion
- 2017-02-23
- First posted
- 2015-03-24
- Last updated
- 2017-02-27
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02395744. Inclusion in this directory is not an endorsement.